Morphine
This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA
Overview
Download & View Morphine as PDF for free.
More details
- Words: 350
- Pages: 2
NURS 1566 Clinical Form 3: Clinical Medications Worksheets Generic Name Morphine Peak 20 Min
Trade Name MorPHINe Onset Rapid
Classification Opioid analgesic
Dose 1-2 mg
Duration 4-5 hr
Why is your patient getting this medication Control of acute pain.
Mechanism of action and indications (Why med ordered) Binds to opiate receptors in the CNS. Alters the perception of and response to painful stimuli while producing generalized CNS depression.
Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) None for this patient
Nursing Process- Assessment (Pre-administration assessment) Assess type, location, and intensity of pain prior to and 20 min following IV administration. Assess level of consciousness, BP, Pulse, and respirations
Route IVP
Time/frequency Q 30min PRN
Normal dosage range 0.8-10 mg/hr; may be preceded by a bolus of 15 mg For IV meds, compatibility with IV drips and/or solutions D5W, D10W, 0.9%NaCl, 0.45% NaCl, Ringer’s or LR, dextrose/Ringer’s or LR I a concentration of 0.1-1 mg/mL or greater for continuous infusion RATE OF ADMINISTRATION: Dose should be titrated to ensure adequate pain relief without excessive sedation, respiratory depression, or hypotension. Nursing Implications (what to focus on) Contraindications/warnings/interactions Hypersensitivity. Some products contain tartrazine, bisulfites, or alcohol and should be avoided in patients with known hypersensitivity. Use caution in head trauma, increased intracranial pressure, Sever renal, hepatic, or pulmonary disease, Hypothyroidism, adrenal insufficiency, history of substance abuse. Common side effects CNS: confusion, sedation, dizziness, dysphoria, euphoria, floating feeling, hallucinations, headache, unusual dreams. EENT: blurred vision, diplopia, miosis. RESP: respiratory depression. CV: hypotension, bradycardia. GI: constipation, nausea, vomiting. GU: urinary retention. DERM: flushing, itching, sweating. MISC: physical dependence, psychological dependence, tolerance. Lab value alterations caused by medicine May increase plasma amylase and lipase levels.
Be sure to teach the patient the following about this medication How and when to ask for pain medication: May cause drowsiness or dizziness. Change position slowly. Do not drink alcohol or other CNS depressants Assessment Evaluation Why would you hold or not give this Check after giving med? Assess level of pain 20 Respirations <10/min and diminished after administration. level of consciousness. Unable to awake patient
Trade Name MorPHINe Onset Rapid
Classification Opioid analgesic
Dose 1-2 mg
Duration 4-5 hr
Why is your patient getting this medication Control of acute pain.
Mechanism of action and indications (Why med ordered) Binds to opiate receptors in the CNS. Alters the perception of and response to painful stimuli while producing generalized CNS depression.
Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) None for this patient
Nursing Process- Assessment (Pre-administration assessment) Assess type, location, and intensity of pain prior to and 20 min following IV administration. Assess level of consciousness, BP, Pulse, and respirations
Route IVP
Time/frequency Q 30min PRN
Normal dosage range 0.8-10 mg/hr; may be preceded by a bolus of 15 mg For IV meds, compatibility with IV drips and/or solutions D5W, D10W, 0.9%NaCl, 0.45% NaCl, Ringer’s or LR, dextrose/Ringer’s or LR I a concentration of 0.1-1 mg/mL or greater for continuous infusion RATE OF ADMINISTRATION: Dose should be titrated to ensure adequate pain relief without excessive sedation, respiratory depression, or hypotension. Nursing Implications (what to focus on) Contraindications/warnings/interactions Hypersensitivity. Some products contain tartrazine, bisulfites, or alcohol and should be avoided in patients with known hypersensitivity. Use caution in head trauma, increased intracranial pressure, Sever renal, hepatic, or pulmonary disease, Hypothyroidism, adrenal insufficiency, history of substance abuse. Common side effects CNS: confusion, sedation, dizziness, dysphoria, euphoria, floating feeling, hallucinations, headache, unusual dreams. EENT: blurred vision, diplopia, miosis. RESP: respiratory depression. CV: hypotension, bradycardia. GI: constipation, nausea, vomiting. GU: urinary retention. DERM: flushing, itching, sweating. MISC: physical dependence, psychological dependence, tolerance. Lab value alterations caused by medicine May increase plasma amylase and lipase levels.
Be sure to teach the patient the following about this medication How and when to ask for pain medication: May cause drowsiness or dizziness. Change position slowly. Do not drink alcohol or other CNS depressants Assessment Evaluation Why would you hold or not give this Check after giving med? Assess level of pain 20 Respirations <10/min and diminished after administration. level of consciousness. Unable to awake patient
Related Documents
Morphine
August 2019 34
Morphine
November 2019 35
Morphine
October 2019 23
Morphine
November 2019 25
Morphine Sulfate
November 2019 29
